Tejnaksh healthcare Financial Statements

Ratio Analysis

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth (29) 17.50 95.80 53.40
Op profit growth 0.88 (28) 61.20 39.20
EBIT growth (15) (29) 73.40 43.10
Net profit growth (1.80) (28) 59.20 37.90
Profitability ratios (%)        
OPM 31 22 36.10 43.80
EBIT margin 26.50 22.20 36.90 41.70
Net profit margin 17.20 12.50 20.30 25
RoCE 13.50 17.70 31.60 28.50
RoNW 3.15 4.12 7.97 6.37
RoA 2.18 2.48 4.35 4.29
Per share ratios ()        
EPS 2.04 2.11 14.40 8.64
Dividend per share -- -- -- --
Cash EPS 1.35 1.41 11 6.68
Book value per share 17.10 15 45.90 36.50
Valuation ratios        
P/E 35.70 17.10 6.41 9.16
P/CEPS 53.90 25.50 8.38 11.80
P/B 4.27 2.40 2.01 2.17
EV/EBIDTA 20.20 9.69 17.40 25.30
Payout (%)        
Dividend payout -- -- -- --
Tax payout (22) (28) (26) (33)
Liquidity ratios        
Debtor days 15.30 5.45 (0.40) --
Inventory days 20.40 14.80 13.10 12
Creditor days (22) (18) (25) (33)
Leverage ratios        
Interest coverage (6.30) (4.90) (5.70) (16)
Net debt / equity 0.21 0.39 0.58 0.65
Net debt / op. profit 0.99 1.60 1.15 1.64
Cost breakup ()        
Material costs (7.50) (7.70) (8.40) (12)
Employee costs (12) (15) (14) (12)
Other costs (50) (55) (41) (32)

Invest wise with Expert advice

Open Demat Account

Invest wise with Expert advice

By continuing, I accept the Terms & Conditions and agree to receive updates on Whatsapp